SectorPharmaceutical
Established Date--
Listing Date13/09/2024
ExchangeNASDAQ Stock Exchange
Full-time Employees63
Fiscal Year Ends31/12
Security TypeCommon stock
Office address11711 N. Meridian Street, Suite 300, Carmel, Indiana 46032
Business
IntroductionMBX Biosciences, Inc., was incorporated as an Indiana limited liability company in August 2018 and transformed into a Delaware corporation in April 2019. The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for endocrine and metabolic diseases. Its R&D pipeline includes drug candidates for hypoparathyroidism, obesity and postbariatric hypoglycemia designed using its proprietary Precision Endocrine Peptide Platform.
